Zenpep (Allergan, Inc.)
Welcome to the PulseAid listing for the Zenpep drug offered from Allergan, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE |
| SUBSTANCE NAME: | PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-10-31 |
| END MARKETING DATE: | 0000-00-00 |
Zenpep HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zenpep from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10000; 34000; 55000([USP’U]/1; [USP’U]/1; [USP’U]/1) |
| START MARKETING DATE: | 2017-10-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-6110_2a30d47f-ebc8-4a4c-88ca-74f4eb317ff3 |
| PRODUCT NDC: | 0023-6110 |
| APPLICATION NUMBER: | NDA022210 |
Other PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE Pharmaceutical Manufacturers / Labelers:
